MVM Inc.

Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics.
Women's Health Weekly; 11/5/2009; 1261 words; Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarsa Therapeutics, Inc. announced that Unigene has...specializing in the life sciences: MVM Life Science Partners, Quaker...see also Unigene Laboratories, Inc. / Tarsa Therapeutics, Inc...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1778 words; ...Separately, MDS Proteomics Inc. and Thermo Finnigan...Proteomics applications. MVM Ltd., of London, raised...close of its second fund, MVM International Life Sciences...Coulter Foundation. MVM Ltd. was founded in 1998...NaPro Biotherapeutics Inc., of Boulder, Colo...

Momenta Secures $19M Series B Funds For Sugar-Based Research.
BIOWORLD Today; 11/4/2009; 1174 words; Staff Writer Momenta Pharmaceuticals Inc. garnered $19 million after closing its second round of venture...Crane said. Boston-based Atlas Venture and London-based MVM Life Science Partners co-led the financing. Returning investors...

Aegerion's Series A Adds $22M For Cholesterol-Lowering Work.
BIOWORLD Today; 11/3/2009; 1169 words; ...February 2005, Aegerion Pharmaceuticals Inc. raised $22.5 million in an oversubscribed...based Alta Partners and Boston-based MVM Life Science Partners. "We actually had...Whitehouse Station, N.J.-based Merck & Co. Inc. called Zocor (simvastatin) and a cholesterol...

Spherics Gets $26M To Push Bioadhesive Drug Delivery.
BIOWORLD Today; 11/3/2009; 1044 words; Staff Writer Spherics Inc. raised $26.4 million in...new investors London-based MVM Life Sciences; St. Louis...International, and Stephen Reeders, of MVM, joined the company's board...news: o Anacor Pharmaceuticals Inc., of Palo Alto, Calif...